资讯

Novo Nordisk Says FDA Accepted New Drug Application for Wegovy Pill
The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
Wall Street Journal3 天
Novo Nordisk Says FDA Accepted New Drug Application for Wegovy Pill
Novo Nordisk NOVO.B2.62%increase; green up pointing triangle said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense ...
Morningstar4 天
Novo Nordisk Says FDA Accepts New Drug Application for Wegovy Pill — Update
Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on ...
FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months
The U.S. Food and Drug Administration (FDA) on Thursday extended the Prescription Drug User Fee Act (PDUFA) action date for ...
Novo Nordisk shares jump as FDA accepts oral Wegovy application
Investing.com -- Novo Nordisk (NYSE: NVO) shares climbed 5.4% Friday after the U.S. Food and Drug Administration accepted the ...
Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application
Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, ...
Medical Dialogues4 天
Alembic Pharma bags USFDA nod for cardiovascular disease drug Ticagrelor in two strengths
Vadodara: Alembic Pharmaceuticals Limited has announced that the US Food & Drug Administration (USFDA) has given final ...
The Manila Times6 天
Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with ...
Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...